Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: U.S. Medical Products

This article was originally published in The Gray Sheet

Executive Summary

U.S. Medical Products: Austin, Texas-based manufacturer of total joint replacements and related instrumentation enters a funding agreement with Smith Management Company of New York City. Under the agreement, U.S. Medical will receive up to $750,000 in a convertible, secured loan and up to an additional $2.3 mil. in secured debt and equity financing. If the promissory notes are converted, Smith would own 80% of the fully diluted outstanding shares in the company. The funds, which augment $4 mil. in gross proceeds raised in an initial public offering that closed last May ("The Gray Sheet" March 7, 1994, p. 12), will "provide the additional capital to overcome" a cash shortage caused by "unanticipated delays in FDA approvals and delays by vendors in delivering products to the company." The delays affected the introduction of U.S. Medical's Consensus total knee system, cleared by FDA via 510(k) in September; the device is being unveiled at the American Academy of Orthopedic Surgeons' Feb. 16-20 annual meeting...
UsernamePublicRestriction

Register

MT003463

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel